{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:51:51Z","timestamp":1753883511546,"version":"3.41.2"},"reference-count":51,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"10","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n            <jats:title>PURPOSE<\/jats:title>\n            <jats:p>Gene fusions are critical oncogenic mutations that drive cancer development and serve as diagnostic and prognostic biomarkers. Despite the increasing cancer burden in India, large-scale analyses of molecular landscapes, particularly gene fusions, have been relatively scarce.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>This retrospective study used RNA-exome data from 1,392 Indian patients with cancer across 15 major cancer types to explore gene fusions. The study used a comprehensive framework that integrated open-source and proprietary tools to detect gene fusions from formalin-fixed paraffin-embedded tumor samples. The process involved RNA extraction, RNA-exome library preparation, and analysis using tools such as FastQC, DRAGEN RNA Pipeline, STAR-Fusion, and FusionInspector. We validated and filtered potential false-positive fusion calls using AGFusion and FusionAnnotator to annotate fusion breakpoints and their functional impact through various in silico tools.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>\n              The study found a notable prevalence of FGFR fusions across cancer types, especially FGFR3, with\n              <jats:italic>FGFR3::TACC3<\/jats:italic>\n              as the most recurrent. Kinase fusions were prevalent in the cohort accounting for 37% of incidence in the patients. We also identified 91 novel potential driver fusions, including those involving\n              <jats:italic>FGFR2<\/jats:italic>\n              ,\n              <jats:italic>MET<\/jats:italic>\n              ,\n              <jats:italic>ESR1<\/jats:italic>\n              , and\n              <jats:italic>PDGFRA.<\/jats:italic>\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>This study underscores the critical role of gene fusions as biomarkers in cancer, extending beyond fusion-driven malignancies to encompass all cancer types. Gene fusions serve as both diagnostic markers and tumor-agnostic therapeutic targets within the current cancer treatment paradigm. Our insights into the prevalence of oncogenic drivers and novel targets expand the understanding of gene fusions, shedding new light on their mechanisms and clinical implications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1200\/go-24-00289","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T20:59:31Z","timestamp":1732222771000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Deep Diving Into the Fusion Across Cancer Types in the Indian Population From Formalin-Fixed Paraffin-Embedded RNA-Exome Data: A Road to Discovering Novel Rearrangements With Clinical Relevance"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4337-5950","authenticated-orcid":true,"given":"Satya Prakash","family":"Khuntia","sequence":"first","affiliation":[{"name":"4baseCare Onco Solutions Pvt. Ltd, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4864-6399","authenticated-orcid":true,"given":"Nilesh","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"4baseCare Onco Solutions Pvt. Ltd, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0559-3074","authenticated-orcid":true,"given":"Vyomesh","family":"Javle","sequence":"additional","affiliation":[{"name":"4baseCare Onco Solutions Pvt. Ltd, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2784-5967","authenticated-orcid":true,"given":"Nishtha AjitSingh","family":"Tanwar","sequence":"additional","affiliation":[{"name":"4baseCare Onco Solutions Pvt. Ltd, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2284-7889","authenticated-orcid":false,"given":"Peddagangannagari","family":"Sreekanthreddy","sequence":"additional","affiliation":[{"name":"4baseCare Onco Solutions Pvt. Ltd, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linu","family":"Varghese","sequence":"additional","affiliation":[{"name":"4baseCare Onco Solutions Pvt. Ltd, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Gowda","sequence":"additional","affiliation":[{"name":"4baseCare Onco Solutions Pvt. Ltd, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anju","family":"Kottlahouse","sequence":"additional","affiliation":[{"name":"4baseCare Onco Solutions Pvt. Ltd, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2572-0189","authenticated-orcid":true,"given":"Pratik","family":"Chandrani","sequence":"additional","affiliation":[{"name":"Tata Memorial Centre, Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9889-2136","authenticated-orcid":true,"given":"Anuradha","family":"Choughule","sequence":"additional","affiliation":[{"name":"Tata Memorial Centre, Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Pange","sequence":"additional","affiliation":[{"name":"Tata Memorial Centre, Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Gupta","sequence":"additional","affiliation":[{"name":"Tata Memorial Centre, Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0191-2744","authenticated-orcid":true,"given":"Vanita","family":"Noronha","sequence":"additional","affiliation":[{"name":"Tata Memorial Centre, Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7691-3995","authenticated-orcid":true,"given":"Vijay Maruti","family":"Patil","sequence":"additional","affiliation":[{"name":"Tata Memorial Centre, Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0483-6254","authenticated-orcid":true,"given":"Raja","family":"Pramanik","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9942-3403","authenticated-orcid":true,"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep Peraje","family":"Nayak","sequence":"additional","affiliation":[{"name":"Fortis Cancer Research Centre, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Babu","sequence":"additional","affiliation":[{"name":"Fortis Cancer Research Centre, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Shetty","sequence":"additional","affiliation":[{"name":"Yenepoya Medical College, Mangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8052-6034","authenticated-orcid":true,"given":"Madan","family":"Kantharaju","sequence":"additional","affiliation":[{"name":"Yenepoya Medical College, Mangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7233-7428","authenticated-orcid":true,"given":"Pramod Shekarappa","family":"Chinder","sequence":"additional","affiliation":[{"name":"AARO Clinic, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aruna","family":"Korlimarla","sequence":"additional","affiliation":[{"name":"Sri Shankara Cancer Hospital &amp; Research Centre, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.S.","family":"Srinath","sequence":"additional","affiliation":[{"name":"Sri Shankara Cancer Hospital &amp; Research Centre, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8858-5004","authenticated-orcid":true,"given":"Kumar","family":"Prabhash","sequence":"additional","affiliation":[{"name":"Tata Memorial Centre, Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giridharan","family":"Periyasamy","sequence":"additional","affiliation":[{"name":"4baseCare Onco Solutions Pvt. Ltd, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kshitij Datta","family":"Rishi","sequence":"additional","affiliation":[{"name":"4baseCare Onco Solutions Pvt. Ltd, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitesh Madan","family":"Goswami","sequence":"additional","affiliation":[{"name":"4baseCare Onco Solutions Pvt. Ltd, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5989-4836","authenticated-orcid":true,"given":"Vidya Harini","family":"Veldore","sequence":"additional","affiliation":[{"name":"4baseCare Onco Solutions Pvt. Ltd, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002517"},{"key":"e_1_3_7_3_2","first-page":"839","article-title":"Molecular methods to detect the Philadelphia chromosome","volume":"10","author":"Hooberman AL","year":"1990","unstructured":"Hooberman AL, Westbrook CA: Molecular methods to detect the Philadelphia chromosome. Clin Lab Med 10:839-855, 1990","journal-title":"Clin Lab Med"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2091"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1593\/neo.07822"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature05945"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5846"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.03.050"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2012.30"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.5005"},{"key":"e_1_3_7_11_2","first-page":"117","article-title":"Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung","volume":"8","author":"Doval DC","year":"2015","unstructured":"Doval DC, Prabhash K, Patil S, et al: Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung. Onco Targets Ther 8:117-123, 2015","journal-title":"Onco Targets Ther"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prnil.2018.03.004"},{"key":"e_1_3_7_13_2","article-title":"History of the growing burden of cancer in India: From antiquity to the 21st century","author":"Smith R","unstructured":"Smith R, Mallath MK: History of the growing burden of cancer in India: From antiquity to the 21st century. JCO Glob Oncol 10.1200\/JGO.19.00048","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"e_1_3_7_15_2","first-page":"199","article-title":"ICH harmonised tripartite guideline: Guideline for good clinical practice","volume":"47","author":"Bhuiyan PS","year":"2001","unstructured":"Bhuiyan PS, Rege NN: ICH harmonised tripartite guideline: Guideline for good clinical practice. J Postgrad Med 47:199-203, 2001","journal-title":"J Postgrad Med"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2018.12.027"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1002792"},{"key":"e_1_3_7_18_2","unstructured":"Andrews S: FastQC: A quality control tool for high throughput sequence data. 2010. http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2016-5266"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.135350.111"},{"key":"e_1_3_7_21_2","article-title":"AGFusion: Annotate and visualize gene fusions","author":"Murphy CD","year":"2016","unstructured":"Murphy CD, Elemento O: AGFusion: Annotate and visualize gene fusions. bioRxiv, 2016. (Cold Spring Harbor Laboratory) https:\/\/doi.org\/10.1101\/080903","journal-title":"bioRxiv"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2016.12.004"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1268"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.1984"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2689"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2019.02.011"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2002-3-3-reviews0004"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1042\/BC20080104"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39878-9"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-0791"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0003-x"},{"key":"e_1_3_7_32_2","first-page":"450","article-title":"Kinase impact assessment in the landscape of fusion genes that retain kinase domains: A pan-cancer study","volume":"19","author":"Kim P","year":"2018","unstructured":"Kim P, Jia P, Zhao Z: Kinase impact assessment in the landscape of fusion genes that retain kinase domains: A pan-cancer study. Brief Bioinform 19:450-460, 2018","journal-title":"Brief Bioinform"},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btt445"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1059"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2020.100037"},{"key":"e_1_3_7_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03999-7"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy025"},{"key":"e_1_3_7_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5577"},{"key":"e_1_3_7_39_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aai7993"},{"key":"e_1_3_7_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408440"},{"key":"e_1_3_7_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxz329"},{"key":"e_1_3_7_42_2","first-page":"475","article-title":"FGFR-TACC gene fusions in human glioma","volume":"19","author":"Lasorella A","year":"2017","unstructured":"Lasorella A, Sanson M, Iavarone A: FGFR-TACC gene fusions in human glioma. Neurooncology 19:475-483, 2017","journal-title":"Neurooncology"},{"key":"e_1_3_7_43_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2199"},{"key":"e_1_3_7_44_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1140"},{"key":"e_1_3_7_45_2","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S218796"},{"key":"e_1_3_7_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186856"},{"key":"e_1_3_7_47_2","doi-asserted-by":"publisher","DOI":"10.6065\/apem.2244114.057"},{"key":"e_1_3_7_48_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0699"},{"key":"e_1_3_7_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0324-7"},{"key":"e_1_3_7_50_2","volume-title":"FDA Approves Entrectinib for Tumors with NTRK Fusions","author":"National Cancer Institute","year":"2019","unstructured":"National Cancer Institute: FDA Approves Entrectinib for Tumors with NTRK Fusions. 2019d. https:\/\/www.cancer.gov\/news-events\/cancer-currents-blog\/2019\/fda-entrectinib-ntrk-fusion"},{"key":"e_1_3_7_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.23029"},{"key":"e_1_3_7_52_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16781"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-24-00289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T20:59:36Z","timestamp":1732222776000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-24-00289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1200\/GO-24-00289"],"URL":"https:\/\/doi.org\/10.1200\/go-24-00289","relation":{},"ISSN":["2687-8941"],"issn-type":[{"type":"electronic","value":"2687-8941"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"2024-06-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2400289"}}